Navigation Links
Celtic Therapeutics and Resolvyx Pharmaceuticals Announce an Alliance in Ophthalmology
Date:10/26/2010

husetts, October 26, 2010 /PRNewswire/ -- Celtic Therapeutics Holdings L.P. (Celtic Therapeutics), a successor firm to Celtic Pharma, and Resolvyx Pharmaceuticals, Inc. (Resolvyx) announced today that they have entered into an option agreement relating to Resolvyx's RX-10045, a late-stage program for the treatment of dry eye syndrome and other ophthalmic conditions. In connection with the RX-10045 option agreement, Celtic Therapeutics purchased a note convertible into Resolvyx equity.

Under the terms of the option agreement, Celtic Therapeutics has an exclusive option to acquire and license rights to Resolvyx's RX-10045, in all eye indications. RX-10045 is scheduled to enter a Phase III randomized, placebo-controlled, multi-center study in 2011. As part of the agreement, Celtic Therapeutics may also license rights to and develop another Resolvyx compound in a topical formulation for ophthalmic indications. Resolvins are a recently discovered family of naturally-occurring, small molecule lipid mediators that can be targeted to treat a wide range of diseases. Resolvins are shown to be highly potent and efficacious across a broad range of pre-clinical models of asthma, atherosclerosis, rheumatoid arthritis, inflammatory bowel disease, dry eye and retinal disease, among others.

Dry eye, one of the most common problems treated by ophthalmologists, and a $1.7 billion global market today, is a chronic, multifactorial disease of the tear ducts and ocular surfaces that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surfaces. RX-10045, a resolvin administered as a topical eye drop, produced dose-dependent, significant improvement on the primary endpoints for both the signs and symptoms of dry eye, and was generally shown to be safe and well tolerated in a large placebo-controlled Phase II study.

"Celtic Therapeutics is excited to invest in Resolvyx's groundbreaking technology, which
'/>"/>

SOURCE Celtic Pharmaceutical Holdings L.P.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Celtic Pharma Announces Issuance of U.S. Patent 7,816,323 for Xerecept® in Combination with Avastin® as a Treatment for Breast and Colon Cancers
2. Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis
3. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
4. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
5. Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009
6. Celtic Pharma Provides Update on XERECEPT(R) Clinical Program
7. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
8. Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics
9. BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
10. Prime Therapeutics Receives 2011 TIPPS Certification
11. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  Decision Resources Group finds ... oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and nephrology) expect ... a biosimilar has been assessed in to be ... choose to prescribe. Other key ... Acceptance of Biosimilars Across Physician Specialties ...
(Date:8/27/2014)... Fla. , Aug. 27, 2014 ... today that it has released a preview of its ... the pharmaceutical industry avoid drug shortages and maintain a ... The Plan, a first for the ... and biopharmaceutical industry members and describes how industry can ...
(Date:8/27/2014)... YORK , Aug. 27, 2014 Reportlinker.com ... in its catalogue: Baby Food Eastern Europe ... Summary "Baby Food Eastern Europe 2014" is a new ... demand prospects in Eastern Europe , ... various trends. This report also examines trends which are ...
Breaking Medicine Technology:Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8
... Several abstracts highlighting CIMZIA,s long-term benefits and value ... American College,of Gastroenterology (ACG), ORLANDO, Fla. Oct. ... by UCB at the American College of Gastroenterology,(ACG) ... the,only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) ...
... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) announced ... Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran ... was presented at the,American College of Gastroenterology (ACG) ... provided data from a preclinical study of,RDEA119, the ...
Cached Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4
(Date:8/27/2014)... Beach, Florida (PRWEB) August 28, 2014 ... Kevin Harrington, Chairman of As Seen On TV, Inc., ... as “The Millionaire Maker”. as Excelerate attendees will learn ... and will have the ability to pitch to an ... World Renowned Business Experts and Millionaire Mentors directly to ...
(Date:8/27/2014)... August 27, 2014 When it comes to ... comfortable bed to sleep without breaking the bank in the ... a new foam mattress set for the master bedroom or ... Bedding Mart has it all during their Labor Day mattress ... some of the best mattresses for the home, while enjoying ...
(Date:8/27/2014)... August 27, 2014 Reviewing the prices ... now be easier for the public when using the ... are promoted in all 50 states in the U.S. ... The different insurers that are generating the rates information ... for adults to use the programmed system without charge. ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 Locating ... require a consumer to present personal information before rates ... the way that life insurance quotes are distributed online ... , The term plans that an adult has access ... by known U.S. companies. The system for quotation distribution ...
(Date:8/27/2014)... 2014 The Latinos In Action Festival ... 7th at the Florida State Fair Grounds from 9am ... art and cultures from around the world. Latinos in ... Go Smart Mobile and Univision Mobile, a service provided ... an estimate of 4,000 people from different backgrounds, cultures ...
Breaking Medicine News(10 mins):Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Life Insurance Quotes for Term Policies Now Found at Insurer Website Online 2Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2
... lead to better understanding of infectious disease processes – ... ,Montreal Researchers working with teams at Massachusetts General Hospital ... in understanding an essential aspect of the immune system. ... systems biology approach, they have developed a model that ...
... forego considerations of quality education for more practical needs, ... meals. // ,The findings are from a new ... the University of North Carolina at Chapel Hill, which ... (pre-K) programs define quality and select programs. The paper ...
... an agreement to support a $ 500 million research to further ... groundbreaking decision to legalise stem cell research, being only the second ... 270 million has already garnered enough support to gain the approval ... Neil M Cohen from D-Union who is one of the bills ...
... looking exteriorly might be healthy internally. They might come under the ... inside! // , Case of Tofi : ,Ben ... the day in his occupation of running a television production company. ... was diagnosed with the help of a MRI to have 3.75 ...
... other “impotence drugs” that boost the production of a ... an erection now also show promise in unmasking// cancer ... attack them, say scientists at the Johns Hopkins Kimmel ... implanted colon and breast tumors showed that tumor size ...
... achieved. This is made possible with the invention of ... material.// It can be coated with drugs and then ... by researchers from the University of Wisconsin-Madison and the ... Neutron Research (NCNR). ,Pharmaceutical compounds can now be ...
Cached Medicine News:Health News:Montreal Researchers And US Develop Model Of Key Immune-System Component 2Health News:Montreal Researchers And US Develop Model Of Key Immune-System Component 3Health News:Families Need More Than Quality Education from Pre-K Programs 2Health News:New Jersey Decides to Support $500 M Stem Cell Research 2Health News:You are Slim.. But are You Sure You are Healthy? 2Health News:“Erectile Dysfunction” Drugs Heighten Natural Anti-Cancer Activi 2Health News:Drugs Delivery Revolutionized by Extremely Stable Glass 2
... laparoscopic procedures, the Advantage Smart Table goes ... tables but is versatile enough to accommodate ... remote, this table remembers positions for various ... multi-articulation or return to level. The simple ...
... complete imaging access, with nearly 100 percent ... imaging C-Arms can pan from head to ... patient. Anesthesiologists will appreciate this table for ... construction, and ease of operation. The key ...
Inquire...
...
Medicine Products: